Relationship between TG/HDL-C ratio and metabolic syndrome risk factors with chronic kidney disease in healthy adult population

Clinical Nutrition

Volumn 34, Issue 5, 2015, Pages 874-880

  Ho, Chih I ^a   Chen, Jau Yuan ^a   Chen, Shou Yen ^a   Tsai, Yi Wen ^a   Weng, Yi Ming ^a   Tsao, Yu Chung ^a   Li, Wen Cheng ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Chronic kidney disease; EGFR; Mean arterial pressure; Metabolic syndrome risk factor; TG HDL C ratio

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ADULT; AREA UNDER THE CURVE; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; FEMALE; GLUCOSE BLOOD LEVEL; HEART ATRIUM PRESSURE; HUMAN; KIDNEY DYSFUNCTION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK FACTOR; TAIWAN; WAIST CIRCUMFERENCE; WAIST TO HEIGHT RATIO; ADOLESCENT; BLOOD; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; BIOMARKERS; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; ROC CURVE; TAIWAN; TRIGLYCERIDES; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84939265511     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2014.09.007     Document Type: Article

References (43)

1. Lopez A.D., Mathers C.D., Ezzati M., Jamison D.T., Murray C.J. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006, 367:1747-1757.
2. Go A.S., Chertow G.M., Fan D., McCulloch C.E., Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004, 351:1296-1305.
3. Kuo H.W., Tsai S.S., Tiao M.M., Yang C.Y. Epidemiological features of CKD in Taiwan. Am J Kidney Dis 2007, 49:46-55.
4. Wen C.P., Cheng T.Y., Tsai M.K., Chang Y.C., Chan H.T., Tsai S.P., et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462,293 adults in Taiwan. Lancet 2008, 371:2173-2182.
5. Bethesda M. US renal data system, USRDS 2012 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States 2012, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.
6. Saland J.M., Ginsberg H.N. Lipoprotein metabolism in chronic renal insufficiency. Pediatr Nephrol 2007, 22:1095-1112.
7. Kannel W.B., Vasan R.S., Keyes M.J., Sullivan L.M., Robins S.J. Usefulness of the triglyceride-high-density lipoprotein versus the cholesterol-high-density lipoprotein ratio for predicting insulin resistance and cardiometabolic risk (from the Framingham offspring cohort). Am J Cardiol 2008, 101:497-501.
8. Di Bonito P., Moio N., Scilla C., Cavuto L., Sibilio G., Sanguigno E., et al. Usefulness of the high triglyceride-to-HDL cholesterol ratio to identify cardiometabolic risk factors and preclinical signs of organ damage in outpatient children. Diabetes Care 2012, 35:158-162.
9. Sung K.C., Ryan M.C., Kim B.S., Cho Y.K., Kim B.I., Reaven G.M. Relationships between estimates of adiposity, insulin resistance, and nonalcoholic fatty liver disease in a large group of nondiabetic Korean adults. Diabetes Care 2007, 30:2113-2118.
10. de Leon A.C., Coello S.D., Gonzalez D.A., Diaz B.B., Rodriguez J.C., Hernandez A.G., et al. Impaired fasting glucose, ancestry and waist-to-height ratio: main predictors of incident diagnosed diabetes in the Canary Islands. Diabet Med 2012, 29:399-403.
11. Hadaegh F., Khalili D., Ghasemi A., Tohidi M., Sheikholeslami F., Azizi F. Triglyceride/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men. Nutr Metab Cardiovasc Dis 2009, 19:401-408.
12. Bittner V., Johnson B.D., Zineh I., Rogers W.J., Vido D., Marroquin O.C., et al. The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia: a report from the women's ischemia syndrome evaluation (WISE). Am Heart J 2009, 157:548-555.
13. Dobiasova M., Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem 2001, 34:583-588.
14. Kang H.T., Shim J.Y., Lee Y.J., Lee J.E., Linton J.A., Kim J.K., et al. Association between the ratio of triglycerides to high-density lipoprotein cholesterol and chronic kidney disease in Korean adults: the 2005 Korean National Health and Nutrition Examination Survey. Kidney Blood Press Res 2011, 34:173-179.
15. Zoppini G., Targher G., Negri C., Stoico V., Gemma M.L., Bonora E. Usefulness of the triglyceride to high-density lipoprotein cholesterol ratio for predicting mortality risk in type 2 diabetes: role of kidney dysfunction. Atherosclerosis 2010, 212:287-291.
16. Shlipak M.G., Fried L.F., Cushman M., Manolio T.A., Peterson D., Stehman-Breen C., et al. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 2005, 293:1737-1745.
17. de Boer I.H., Astor B.C., Kramer H., Palmas W., Seliger S.L., Shlipak M.G., et al. Lipoprotein abnormalities associated with mild impairment of kidney function in the multi-ethnic study of atherosclerosis. Clin J Am Soc Nephrol 2008, 3:125-132.
18. Lee P.H., Chang H.Y., Tung C.W., Hsu Y.C., Lei C.C., Chang H.H., et al. Hypertriglyceridemia: an independent risk factor of chronic kidney disease in Taiwanese adults. Am J Med Sci 2009, 338:185-189.
19. McLaughlin T., Reaven G., Abbasi F., Lamendola C., Saad M., Waters D., et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?. Am J Cardiol 2005, 96:399-404.
20. Laws A., Reaven G.M. Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations. J Intern Med 1992, 231:25-30.
21. Li C., Ford E.S., Meng Y.X., Mokdad A.H., Reaven G.M. Does the association of the triglyceride to high-density lipoprotein cholesterol ratio with fasting serum insulin differ by race/ethnicity?. Cardiovasc Diabetol 2008, 7:4.
22. Salazar M.R., Carbajal H.A., Espeche W.G., Leiva Sisnieguez C.E., Balbin E., Dulbecco C.A., et al. Relation among the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio, insulin resistance, and associated cardio-metabolic risk factors in men and women. Am J Cardiol 2012, 109:1749-1753.
23. Toth P.P., Potter D., Ming E.E. Prevalence of lipid abnormalities in the United States: the national health and nutrition examination survey 2003-2006. J Clin Lipidol 2012, 6:325-330.
24. Ma Y.C., Zuo L., Chen J.H., Luo Q., Yu X.Q., Li Y., et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 2006, 17:2937-2944.
25. Levey A.S., Coresh J., Balk E., Kausz A.T., Levin A., Steffes M.W., et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003, 139:137-147.
26. Kitiyakara C., Yamwong S., Cheepudomwit S., Domrongkitchaiporn S., Unkurapinun N., Pakpeankitvatana V., et al. The metabolic syndrome and chronic kidney disease in a Southeast Asian cohort. Kidney Int 2007, 71:693-700.
27. Chen J., Muntner P., Hamm L.L., Jones D.W., Batuman V., Fonseca V., et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004, 140:167-174.
28. Kurella M., Lo J.C., Chertow G.M. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005, 16:2134-2140.
29. Vaziri N.D. Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. Am J Physiol Renal Physiol 2006, 290:F262-F272.
30. Magil A.B. Interstitial foam cells and oxidized lipoprotein in human glomerular disease. Mod Pathol 1999, 12:33-40.
31. Wheeler D.C., Chana R.S. Interactions between lipoproteins, glomerular cells and matrix. Miner Electrolyte Metab 1993, 19:149-164.
32. Rovin B.H., Tan L.C. LDL stimulates mesangial fibronectin production and chemoattractant expression. Kidney Int 1993, 43:218-225.
33. Fox C.S., Larson M.G., Leip E.P., Culleton B., Wilson P.W., Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA 2004, 291:844-850.
34. Li W.C., Chen I.C., Chang Y.C., Loke S.S., Wang S.H., Hsiao K.Y. Waist-to-height ratio, waist circumference, and body mass index as indices of cardiometabolic risk among 36,642 Taiwanese adults. Eur J Nutr 2013, 52:57-65.
35. Jayawardana R., Ranasinghe P., Sheriff M.H., Matthews D.R., Katulanda P. Waist to height ratio: a better anthropometric marker of diabetes and cardio-metabolic risks in South Asian adults. Diabetes Res Clin Pract 2013, 99:292-299.
36. Bakris G.L., Weir M.R., Shanifar S., Zhang Z., Douglas J., van Dijk D.J., et al. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study. Arch Intern Med 2003, 163:1555-1565.
37. Pohl M.A., Blumenthal S., Cordonnier D.J., De Alvaro F., Deferrari G., Eisner G., et al. Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations. J Am Soc Nephrol 2005, 16:3027-3037.
38. Jacobsen P., Rossing K., Tarnow L., Rossing P., Mallet C., Poirier O., et al. Progression of diabetic nephropathy in normotensive type 1 diabetic patients. Kidney Int Suppl 1999, 71:S101-S105.
39. Klahr S., Schreiner G., Ichikawa I. The progression of renal disease. N Engl J Med 1988, 318:1657-1666.
40. Bidani A.K., Griffin K.A. Long-term renal consequences of hypertension for normal and diseased kidneys. Curr Opin Nephrol Hypertens 2002, 11:73-80.
41. Hebert L.A., Agarwal G., Sedmak D.D., Mahan J.D., Becker W., Nagaraja H.N. Proximal tubular epithelial hyperplasia in patients with chronic glomerular proteinuria. Kidney Int 2000, 57:1962-1967.
42. Ravera M., Re M., Deferrari L., Vettoretti S., Deferrari G. Importance of blood pressure control in chronic kidney disease. J Am Soc Nephrol 2006, 17:S98-S103.
43. Guh J.Y., Chen H.C., Tsai J.F., Chuang L.Y. Herbal therapy is associated with the risk of CKD in adults not using analgesics in Taiwan. Am J Kidney Dis 2007, 49:626-633.